A bladder preserving protocol comprising combined external-beam radiotherapy and interstitial brachytherapy for the treatment of bladder cancer has been reported as a viable alternative to cystectomy.

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

"We found CKD to be independently associated with a higher likelihood of nonorgan confined disease and lymph node metastases as well as postoperative transfusion and 90-day readmissions." – Nguyen, et ...

PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 ...

"The main strength of this study is the use of a nationwide population-based cohort encompassing nearly all patients with bladder cancer undergoing RC over 8 years, with detailed clinicopathological, ...

A retrospective study showed that recurrence of bladder cancer after radical cystectomy can occur up to 4 years after surgery. Patients who have no residual disease following radical cystectomy for ...

Bladder removal (radical cystectomy) is an effective treatment option for muscle-invasive bladder cancer but still a major operation. MSK is taking a leading role in helping more people with bladder ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

New data show that a large subset of patients with muscle-invasive bladder cancer (MIBC) can avoid cystectomy and enjoy long-term, bladder-intact, disease-free survival. Among 64 study participants ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its ...